Bank of Montreal’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $212M | Buy |
427,448
+36,972
| +9% | +$16.4M | 0.07% | 225 |
|
|
2026
Q1 | $174M | Sell |
390,476
-37,004
| -9% | -$17.3M | 0.06% | 243 |
|
|
2025
Q4 | $194M | Buy |
427,480
+8,022
| +2% | +$3.46M | 0.07% | 219 |
|
|
2025
Q3 | $164M | Buy |
419,458
+56,423
| +16% | +$23.6M | 0.06% | 222 |
|
|
2025
Q2 | $162M | Sell |
363,035
-50,652
| -12% | -$23.3M | 0.08% | 188 |
|
|
2025
Q1 | $201M | Sell |
413,687
-167,494
| -29% | -$78.1M | 0.1% | 157 |
|
|
2024
Q4 | $234M | Buy |
581,181
+23,964
| +4% | +$11.1M | 0.11% | 144 |
|
|
2024
Q3 | $258M | Buy |
557,217
+45,789
| +9% | +$22M | 0.11% | 144 |
|
|
2024
Q2 | $243M | Buy |
511,428
+4,326
| +0.9% | +$1.88M | 0.07% | 151 |
|
|
2024
Q1 | $212M | Sell |
507,102
-67,025
| -12% | -$28.3M | 0.06% | 168 |
|
|
2023
Q4 | $235M | Buy |
574,127
+50,773
| +10% | +$18.8M | 0.07% | 157 |
|
|
2023
Q3 | $184M | Buy |
523,354
+45,439
| +10% | +$15.9M | 0.06% | 164 |
|
|
2023
Q2 | $168M | Buy |
477,915
+40,477
| +9% | +$13.6M | 0.06% | 170 |
|
|
2023
Q1 | $138M | Buy |
437,438
+69,437
| +19% | +$20.8M | 0.06% | 188 |
|
|
2022
Q4 | $107M | Buy |
368,001
+92,547
| +34% | +$28.2M | 0.05% | 234 |
|
|
2022
Q3 | $81K | Sell |
275,454
-100,951
| -27% | -$29M | 0.04% | 262 |
|
|
2022
Q2 | $106K | Buy |
376,405
+4,932
| +1% | +$1.32M | 0.05% | 232 |
|
|
2022
Q1 | $96M | Buy |
371,473
+29,599
| +9% | +$7.02M | 0.05% | 277 |
|
|
2021
Q4 | $76.1M | Sell |
341,874
-711,485
| -68% | -$138M | 0.04% | 328 |
|
|
2021
Q3 | $192M | Buy |
1,053,359
+114,535
| +12% | +$22.4M | 0.09% | 201 |
|
|
2021
Q2 | $185M | Buy |
938,824
+123,447
| +15% | +$25.8M | 0.09% | 189 |
|
|
2021
Q1 | $171M | Buy |
815,377
+342,415
| +72% | +$75.2M | 0.11% | 157 |
|
|
2020
Q4 | $111M | Buy |
472,962
+89,028
| +23% | +$20.4M | 0.07% | 229 |
|
|
2020
Q3 | $100M | Sell |
383,934
-87,901
| -19% | -$24.3M | 0.08% | 193 |
|
|
2020
Q2 | $139M | Sell |
471,835
-15,599
| -3% | -$4.23M | 0.13% | 145 |
|
|
2020
Q1 | $118M | Sell |
487,434
-31,034
| -6% | -$7.12M | 0.14% | 135 |
|
|
2019
Q4 | $114M | Buy |
518,468
+161,286
| +45% | +$32.6M | 0.09% | 207 |
|
|
2019
Q3 | $60.5M | Buy |
357,182
+22,577
| +7% | +$3.99M | 0.05% | 297 |
|
|
2019
Q2 | $61.4M | Buy |
334,605
+40,392
| +14% | +$7.06M | 0.05% | 312 |
|
|
2019
Q1 | $54.1M | Buy |
294,213
+7,488
| +3% | +$1.38M | 0.05% | 324 |
|
|
2018
Q4 | $47.5M | Sell |
286,725
-23,156
| -7% | -$4.01M | 0.04% | 334 |
|
|
2018
Q3 | $59.7M | Buy |
309,881
+58,738
| +23% | +$10.5M | 0.05% | 332 |
|
|
2018
Q2 | $42.7M | Sell |
251,143
-274,772
| -52% | -$42.6M | 0.04% | 393 |
|
|
2018
Q1 | $85.7M | Buy |
525,915
+177,416
| +51% | +$29M | 0.08% | 245 |
|
|
2017
Q4 | $52.2M | Buy |
348,499
+38,956
| +13% | +$5.77M | 0.05% | 350 |
|
|
2017
Q3 | $47.1M | Buy |
309,543
+101,376
| +49% | +$15.3M | 0.04% | 355 |
|
|
2017
Q2 | $26.8M | Buy |
208,167
+49,427
| +31% | +$5.95M | 0.03% | 509 |
|
|
2017
Q1 | $17.4M | Buy |
158,740
+10,160
| +7% | +$894K | 0.02% | 607 |
|
|
2016
Q4 | $12.1M | Sell |
148,580
-24,476
| -14% | -$1.99M | 0.01% | 733 |
|
|
2016
Q3 | $15.1M | Buy |
173,056
+122
| +0.1% | +$11.5K | 0.02% | 650 |
|
|
2016
Q2 | $14.9M | Buy |
172,934
+142
| +0.1% | +$12.3K | 0.02% | 647 |
|
|
2016
Q1 | $13.7M | Buy |
172,792
+19,064
| +12% | +$1.72M | 0.01% | 618 |
|
|
2015
Q4 | $19.3M | Buy |
153,728
+21,242
| +16% | +$2.56M | 0.02% | 497 |
|
|
2015
Q3 | $13.8M | Sell |
132,486
-8,538
| -6% | -$1.1M | 0.02% | 583 |
|
|
2015
Q2 | $17.4M | Buy |
141,024
+11,102
| +9% | +$1.4M | 0.02% | 572 |
|
|
2015
Q1 | $15.3M | Sell |
129,922
-128,331
| -50% | -$15.4M | 0.02% | 616 |
|
|
2014
Q4 | $30.7M | Sell |
258,253
-48,664
| -16% | -$5.48M | 0.03% | 369 |
|
|
2014
Q3 | $34.5M | Buy |
306,917
+232,359
| +312% | +$22.1M | 0.04% | 352 |
|
|
2014
Q2 | $7.06M | Buy |
74,558
+25,397
| +52% | +$1.78M | 0.01% | 959 |
|
|
2014
Q1 | $3.48M | Buy |
49,161
+10,079
| +26% | +$798K | ﹤0.01% | 1081 |
|
|
2013
Q4 | $2.9M | Buy |
39,082
+2,997
| +8% | +$209K | ﹤0.01% | 1028 |
|
|
2013
Q3 | $2.74M | Sell |
36,085
-38,563
| -52% | -$3.07M | ﹤0.01% | 1019 |
|
|
2013
Q2 | $5.98M | Buy |
+74,648
| New | +$5.5M | 0.01% | 671 |
|
Other funds holding VRTX
VCM
VPM
Bank of Montreal's VRTX Position: Q2 2026 in Review
Bank of Montreal increased its Vertex Pharmaceuticals (VRTX) stake by 9.5% in Q2 2026, buying an estimated $16.4M and bringing the position to 427,448 shares worth $212M. The position accounts for 0.07% of the portfolio, ranked #225.
Bank of Montreal first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $258M in Q3 2024. 1,436 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Bank of Montreal held 427,448 shares of Vertex Pharmaceuticals worth $212M as of Q2 2026.
- Bank of Montreal bought 36,972 Vertex Pharmaceuticals shares in Q2 2026, an estimated $16.4M.
- Vertex Pharmaceuticals made up 0.07% of Bank of Montreal's portfolio in Q2 2026, its #225 holding.
- Bank of Montreal first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Bank of Montreal's Vertex Pharmaceuticals position peaked at $258M in Q3 2024.
- 1,436 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.